Immutep (IMMP) Common Equity (2011 - 2025)
Immutep's (IMMP) quarterly Common Equity came in at $64.9 million in Q4 2025, down 42.43% YoY from $112.8 million in Q4 2024, and down 29.41% on a QoQ basis from $92.0 million in Q2 2025.
Immutep (IMMP) Common Equity (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Common Equity data on file, last reported at $64.9 million in Q4 2025.
- Quarterly Common Equity fell 42.43% year-over-year to $64.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $64.9 million (down 42.43% YoY) and the FY2025 annual result came in at $92.0 million, down 26.35% from the prior year.
- Common Equity declined to $64.9 million in Q4 2025, from $92.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $124.9 million in Q2 2024 to a low of $50.4 million in Q4 2022.
- A 5-year average of $81.5 million and a median of $77.3 million in 2021 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity jumped 158.52% — and 2025, when it tumbled 42.43%.
- Tracing IMMP's Common Equity over 5 years: stood at $79.3 million in 2021, then tumbled by 36.48% to $50.4 million in 2022, then jumped by 49.41% to $75.3 million in 2023, then surged by 49.82% to $112.8 million in 2024, then plunged by 42.43% to $64.9 million in 2025.
- The last three Common Equity figures came in at $64.9 million (Q4 2025), $92.0 million (Q2 2025), and $112.8 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | 64.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 64.93 Mn |
| Jun 30, 2025 | 91.99 Mn |
| Dec 31, 2024 | 112.79 Mn |
| Jun 30, 2024 | 124.90 Mn |
| Dec 31, 2023 | 75.28 Mn |
| Jun 30, 2023 | 91.21 Mn |
| Dec 31, 2022 | 50.39 Mn |
| Jun 30, 2022 | 67.38 Mn |
| Dec 31, 2021 | 79.32 Mn |
| Jun 30, 2021 | 56.42 Mn |
| Dec 31, 2020 | 44.36 Mn |
| Jun 30, 2020 | 21.83 Mn |
| Dec 31, 2019 | 19.15 Mn |
| Jun 30, 2019 | 17.08 Mn |
| Dec 31, 2018 | 24.05 Mn |
| Jun 30, 2018 | 25.38 Mn |
| Jun 30, 2017 | 19.93 Mn |
| Mar 31, 2017 | 21.56 Mn |
| Jun 30, 2016 | 26.37 Mn |
| Jun 30, 2015 | 19.19 Mn |